Waltham, MA, United States of America

Repligen Corporation


USPTO Granted Patents = 132

% Expired Patents = 6.1



Trademarks = 38

Forward Citations = 1,233

Loading Chart...
Loading Chart...

109 inventors (with patents filed for the assignee):

goldMedal Michael C Gagne (17 out of 37 patents)

silverMedal Steven V Cates (15 out of 29 patents)

bronzeMedal Walter C Herlihy (15 out of 15 patents)

4 Michael Bransby (13 out of 13 patents)

5 Rudolf Pavlik (12 out of 16 patents)

6 Dean C Richards (11 out of 21 patents)

7 Derek Carroll (9 out of 9 patents)

8 James Ronald Peyser (7 out of 7 patents)

9 Vincent P Pigiet (7 out of 8 patents)

10 Theodore E Maione (7 out of 7 patents)

11 Philip Yuen (6 out of 6 patents)

12 Scott Bendon (6 out of 10 patents)

13 Algis Anilionis (6 out of 6 patents)

14 Erik Fiedler (5 out of 22 patents)

15 Ulrich Haupts (5 out of 15 patents)


Core Competencies:
Filtration Units
Chromatography
Tangential Flow Filtration
Fluid Monitoring
Bioreactor
Affinity Chromatography
Pressure Relief Valve
Fc Binding Proteins
Disposable Pumphead
Sterilizing Columns
Fluid Plug
Micro Bioreactor

132 patents:

Repligen Corporation is a bioprocessing company that offers innovative solutions for the development and manufacturing of biologic drugs. With a focus on improving bioproduction efficiency and productivity, Repligen provides a range of products and technologies including Protein A ligands, chromatography resins, filtration systems, and Single-Use technologies. Their solutions help biopharmaceutical companies accelerate and improve their bioprocessing workflows, leading to cost-effective and high-quality manufacturing of biologics.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Repligen Corporation
132 Patents

#13 in Waltham, MA

#155 in Massachusetts

#2,935 in US

#6,085 in the World

Waltham, MA (US)
Waltham, MA, United States of America
Forward Citations = 1,233

109 inventors:

Please report any incorrect information to [email protected]
Loading…